AeroLeads people directory · profile
Alyson Smith Email & Phone Number
Director at Pfizer
at
Callio Therapeutics
1 work email found
@seagen.com
2 phones found area 307
LinkedIn matched
✓ Verified May 2026
4 data sources
Profile completeness 100%
Current company
Role
Director at Pfizer
Location
Bothell, Washington, United States
Company size
Who is Alyson Smith? Overview
A concise factual answer block for searchers comparing this professional profile.
Quick answer
Alyson Smith is listed as Director at Pfizer at Callio Therapeutics, a company with 10 employees, based in Bothell, Washington, United States. AeroLeads shows a work email signal at seagen.com, phone signal with area code 307, and a matched LinkedIn profile for Alyson Smith.
Alyson Smith previously worked as Director of ADC Immunology at Pfizer and Director at Seagen. Alyson Smith holds Ph.D., Molecular Pharmacology And Experimental Therapeutics from Mayo Clinic Graduate School Of Biomedical Sciences.
Company email context
Email format at Callio Therapeutics
This section adds company-level context without repeating Alyson Smith's masked contact details.
{first_initial}{last}@seagen.com
86% confidence
AeroLeads found 1 current-domain work email signal for Alyson Smith. Compare company email patterns before reaching out.
Profile bio
About Alyson Smith
Passionate about changing lives through innovative discovery science. I am currently a Director at Pfizer, a focused on 'outdoing cancer' and revolutionizing cancer care. I have extensive experience across disciplines leading teams doing innovative research in a various industry settings. Focused in immunology, vaccinology and oncology drug discovery and development. All opinions expressed are my own.
Listed skills include Flow Cytometry, Cell Culture, Cell Biology, Protein Chemistry, and 25 others.
Current workplace
Alyson Smith's current company
Company context helps verify the profile and gives searchers a useful next step.
Callio Therapeutics
11 roles
Alyson Smith work experience
A career timeline built from the work history available for this profile.
Director Of Adc Immunology
Current
Dec 2023 - Present
Director
Apr 2022 - Dec 2023
Associate Director, Immunology
Jun 2021 - Apr 2022
Principal Scientist, Immunology
May 2018 - Jun 2021
Director Of Immunology
Managed immunology laboratory personnel (4 Sr. scientists) developing and testing multiple classes of novel innate immune modulating compounds. Managed work for a variety of external contract agencies while interfacing with external collaborators. Collaborated with leaders and cross-functional teams (synthetic chemistry, process chemistry and formulations).
Jul 2016 - May 2018
Assistant Research Professor
Designed experimental plans and managed laboratory scientists preforming in vitro and in vivo experiments to investigate new small molecule innate immune receptor agonists, including several TLR (7/8 and 4) and C-type lectin receptors, for development of novel adjuvants for use in next generation vaccines, as cancer immunotherapies and treatments for.
Jan 2016 - May 2018
Postdoctoral Scientist
- Design and direct industrial research projects focused on developing and screening novel pathogen-recognition receptor agonist compounds as vaccine adjuvants for oncology and infectious diseases. Specifically.
- Lead and supervise immunology cell-based assay development team; both in-house team and external, academic collaborators o Generated many different engineered reporter cell lines for compound screening o Screened.
- Devised and generated initial data with a multi-disciplinary team (chemist and formulations scientist) to propose an innovative business idea to top management – novel cancer vaccine strategy; currently being patented
- Co-wrote and edited the technical proposal for the now fully funded, multi-institutional, NIH adjuvant development grant BAA-NIAID-DAIT-NIHAI2013168 – $13.4 million/5 years
- Technical and regulatory document writing and editing; presentation of data and research plans to internal and external entities on regular (monthly) basis
Jun 2012 - Dec 2015
Postdocotral Research Fellow
- Conceived and led a multi-disciplinary research team to utilize patient-specific induced pluripotent stem (iPS) cells to regenerate hypertrophied ventricles in pediatric patients with a congenital heart disease called.
- Named inventor on patent, filed December 2014
- Authored a grant that secured $50K in funding for maximizing the cardiac reparative capacity of therapeutic stem cells by pharmacologically purging teratoma-forming cells
- Mentored several summer and graduate students.
- Learned and applied project management principles, and project management software, to enhance deliverables in basic research
Mar 2011 - Jun 2012
Predoctoral Student
- Designed and executed research on discovery of novel post translational mechanisms of regulation of pro-apoptotic BH3-only proteins and determining how those mechanisms regulate induction of apoptosis in response to.
- Experience using various molecular biology/biochemistry and human cellular biology techniques (siRNA, cloning/transgene expression, antibody production, flow cytometry, westerns, qPCR, etc.) to delineate pathways.
- Studied lymphoid malignancies mechanism(s) of resistance to an anti-cancer agent
- Trainee recipient of Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training grant (T32)
Jul 2006 - Feb 2011
Research Aide
- Genetic engineering, expression and mechanical testing of synthetic spider silk protein, transgenically produced in alfalfa and Arabidopsis. Analysis of the conserved N-terminal domains in major ampullate spidroin.
- Recipient of National Science Foundation EPSCoR Undergraduate Research Fellowship, 3x
Aug 2002 - May 2006
2 education records
Alyson Smith education
Ph.D., Molecular Pharmacology And Experimental Therapeutics
Mayo Clinic Graduate School Of Biomedical Sciences
Bachelor Of Science, Molecular Biology And Chemistry
University Of Wyoming
FAQ
Frequently asked questions about Alyson Smith
Quick answers generated from the profile data available on this page.
What company does Alyson Smith work for?
Alyson Smith works for Callio Therapeutics.
What is Alyson Smith's role at Callio Therapeutics?
Alyson Smith is listed as Director at Pfizer at Callio Therapeutics.
What is Alyson Smith's email address?
AeroLeads has found 1 work email signal at @seagen.com for Alyson Smith at Callio Therapeutics.
What is Alyson Smith's phone number?
AeroLeads has found 2 phone signal(s) with area code 307 for Alyson Smith at Callio Therapeutics.
Where is Alyson Smith based?
Alyson Smith is based in Bothell, Washington, United States while working with Callio Therapeutics.
What companies has Alyson Smith worked for?
Alyson Smith has worked for Callio Therapeutics, Pfizer, Seagen, Inimmune, and University Of Montana.
How can I contact Alyson Smith?
You can use AeroLeads to view verified contact signals for Alyson Smith at Callio Therapeutics, including work email, phone, and LinkedIn data when available.
What schools did Alyson Smith attend?
Alyson Smith holds Ph.D., Molecular Pharmacology And Experimental Therapeutics from Mayo Clinic Graduate School Of Biomedical Sciences.
What skills is Alyson Smith known for?
Alyson Smith is listed with skills including Flow Cytometry, Cell Culture, Cell Biology, Protein Chemistry, Molecular Biology, Stem Cells, Cell, and Vaccines.
Find 750M verified contacts
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial